Financing the Delivery of Vaccines to Children and Adolescents: Challenges to the Current System-Reference-Cited by-同舟云学术

Financing the Delivery of Vaccines to Children and Adolescents: Challenges to the Current System

Published:2009-12-01 Issue:Supplement_5 Volume:124 Page:S548-S557
ISSN:0031-4005
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Lindley Megan C.¹,Shen Angela K.²,Orenstein Walter A.³,Rodewald Lance E.¹,Birkhead Guthrie S.⁴⁵⁶

Affiliation:

1. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

2. National Vaccine Program Office

3. Emory Vaccine Center, Emory University, Atlanta, Georgia

4. Office of Public Health, New York State Department of Health, Albany, New York

5. Department of Epidemiology, School of Public Health, University at Albany, Albany, New York

6. National Vaccine Advisory Committee, US Department of Health and Human Services, Washington, DC

Abstract

Recent increases in the number and costs of vaccines routinely recommended for children and adolescents have raised concerns about the ability of the current vaccine financing and delivery systems to maintain access to recommended vaccines without financial barriers. Here we review the current state of US financing for vaccine delivery to children and adolescents and identify challenges that should be addressed to ensure future access to routinely recommended vaccines without financial barriers. Challenges were considered from the perspectives of vaccine providers; state and local governments; insurers, employers, and other health care purchasers; vaccine manufacturers; and consumers.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatrics/article-pdf/124/Supplement_5/S548/891986/zpe3120900s548.pdf

Reference66 articles.

1. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18):2155–2163

2. Zhou F, Santoli J, Messonnier ML, et al. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Arch Pediatr Adolesc Med. 2005;159(12):1136–1144

3. Institute of Medicine. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: National Academies Press; 2004

4. Bondi MA, Harris JR, Atkins D, French ME, Umland B. Employer coverage of clinical preventive services in the United States. Am J Health Promot. 2006;20(3):214–222

5. McPhillips-Tangum C, Rehm B, Hilton O. Immunization practices and policies: a survey of health insurance plans. AHIP Cover. 2006;47(1):32–37

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of the Medicaid Reimbursement Bump on Influenza Vaccination Rates Among US Teens: Evidence from the National Immunization Survey–Teen 2011–2020;The Journal of the American Board of Family Medicine;2023-12-01

2. Immunization in the United States;Plotkin's Vaccines;2023

3. Pediatric COVID-19 Health Disparities and Vaccine Equity;Journal of the Pediatric Infectious Diseases Society;2022-09-17

4. Viral Vaccines;Encyclopedia of Infection and Immunity;2022

5. Pediatricians’ Experiences With and Perceptions of the Vaccines for Children Program;Pediatrics;2020-03-01